Toth Financial Advisory Corp Beam Therapeutics Inc. Transaction History

Toth Financial Advisory Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$29.86 - $62.36 $1,493 - $3,118	-50 Closed	0 $0
Q1 2022 Apr 26, 2022	SELL	$53.73 - $82.16 $2,686 - $4,108	-50 Reduced 50.0%	50 $3,000
Q3 2020 Oct 16, 2020	BUY	$19.0 - $30.57 $1,900 - $3,057	100 New	100 $2,000

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Toth Financial Advisory Corp, based on Form 13F filings with the SEC.

Stay updated on Toth Financial Advisory Corp with notifications on news.